Organisation paid for research Program year 2022 Source: CMS Open Payments

Activmed Practices & Research

Neither a doctor nor a teaching hospital

Research payments

$10,198

9 payments

Through program year 2022, Activmed Practices & Research is reported as receiving $10,198 in research payments, across 9 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$163	2
2021	Research	$731	3
2020	Research	$129	1
2019	Research	$9,175	3

Breakdown

Who paid Research payments · program years 2019–2022

AMAG Pharmaceuticals, Inc. $9,175 3 payments
Ucb SA $615 2 payments
Amgen Inc. $408 4 payments

Studies the money was for Research payments · program years 2019–2022

Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone $9,175 3 payments
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $615 2 payments
Random DB P3 Study in adult subjects with moderate to severe plaque psoriasis $181 1 payment
Efficacy/Safety Study of Apremilast in Pedi Subjects With Moderate to Severe Plaque PSO (PPSO-003) $129 1 payment
ABP 654 P3 PsO Study $94 1 payment
P3 switching study PK; plaque psoriasis $4 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.